Abdul Rahman Jazieh, Chief Executive Officer at Innovative Healthcare Institute, shared a post on LinkedIn:
“The Journal of Immunotherapy and Precision Oncology (JIPO) got an impact factor of 3.2 and expected to rise significantly next year.
We appreciate your help in listing the journal in your hospital or university library.
It is free and hopefully it will reach more readers.
Thanks for your help.”
More from Abdul Rahman Jazieh on OncoDaily.